Industrial production and prediction markets accounted for the week’s two largest U.S. startup financings. Re:Build raised $2.1 billion, while Kalshi secured $1 billion at a $40 billion post-money valuation. Together, those rounds make up most of the capital in this week’s top 10, though they represent very different bets: one on bringing industrial work into a single production platform, the other on a marketplace built around trading on future events. The remaining deals span construction automation, biotech, batteries and AI infrastructure. The concentration at the top is striking; a handful of large financings can shape the weekly picture even when activity elsewhere is spread across very different industries.
Industrial and market platforms lead
Framingham, Massachusetts-based Re:Build works with industrial companies and product innovators from design through large-scale production. It raised $2.1 billion, with General Catalyst and JPMorganChase leading the financing. At six years old, the company is still relatively young for a business spanning work that can extend from product development into manufacturing. That breadth gives the round a different character from a conventional software financing: the company’s ambitions are tied to physical production capacity and the operational demands that come with it.
The size alone makes the deal stand out, but it doesn't explain how the capital will be deployed or what milestones investors expect. Industrial businesses often face practical constraints that software companies can avoid, including the coordination of design, equipment, production processes and customer needs. Re:Build’s model puts those activities under one company’s umbrella. If you're working in this space, the useful question is whether that structure can make complex production work easier to manage at scale.
Kalshi’s $1 billion Series G was led by Wellington Management and Sequoia Capital. The New York-based predictions marketplace said its annualized trading volume has surpassed $1 trillion. That figure signals substantial activity, though annualized volume is a run-rate measure rather than a report of completed trading over a full year. Its stated $40 billion post-money valuation makes the round one of the week’s defining deals by both size and valuation.
Here's the thing: a large trading-volume figure and a high valuation describe different parts of a business. Volume indicates how much trading is taking place on an annualized basis; it doesn't, by itself, show revenue, profitability or how durable demand will be. The round puts a substantial price on the company’s position in a market where participation and confidence in the platform matter. And yet, the source offers no detail on the terms beyond the valuation, so the headline figure can't answer every question about the financing.
Automation and AI draw substantial checks
Bedrock Robotics raised $600 million in a Series C led by CapitalG and Emergence Capital. The San Francisco company develops autonomous systems for heavy construction equipment. The financing brings its total funding to nearly $1 billion and values it at $4.1 billion after the round. Those figures show strong investor appetite for construction automation, a field where the technology has to operate amid physical constraints and changing job-site conditions.
That makes the category harder to assess from funding totals alone. Autonomous systems for heavy equipment must prove their value in practical settings, where reliability and integration with existing work can matter as much as technical capability. The financing gives Bedrock resources to develop its systems, but the announcement doesn't specify how quickly they’ll be deployed or what commercial milestones the company has reached.
Enterprise software and computing infrastructure also attracted capital. Serval, a two-year-old San Francisco startup developing coding agents for enterprise automation, raised $150 million in a Series C led by Sequoia Capital at a $3 billion valuation. The round reflects demand for software that can take on coding tasks within businesses, though the announcement doesn't say how much work the agents now handle or how customers measure their results.
General Compute brought in $100 million in Series A funding from Blackbird and Abstract. The AI cloud provider is building infrastructure around inference chips from Cerebras Systems, SambaNova and Positron AI, competitors to Nvidia. Its approach points to a broader effort to build computing capacity around hardware choices beyond Nvidia’s products. The commercial test will be whether customers can get the performance and access they need; the announcement doesn't provide operating data that would settle that question.
Foundry Robotics raised $100 million in a Series A led by Marlinspike. The Emeryville, California-based startup is building and operating autonomous factories. Hex Technologies, which is developing an AI-native data analytics platform, also raised $100 million. Peak XV and 137 Ventures led the financing, valuing the San Francisco company at $1.2 billion. The pairing underscores how the week’s funding reached both physical automation and software used to work with data, though the companies face different paths from product development to sustained customer use.
Biotech, batteries and propulsion
Dren Bio secured $350 million in a round led by Juvia Group and Lightspeed Venture Partners. The San Carlos, California-based antibody therapeutics developer plans to use the funding to advance trials for its blood cancer therapies. Its pipeline also targets autoimmune diseases. Clinical development can require substantial capital before a therapy’s prospects are clear, so the announced use of funds points to a long process of testing rather than an immediate commercial payoff.
The breadth of Dren Bio’s pipeline may offer more than one avenue for development, but the source doesn't identify trial stages, timelines or outcomes. Those details matter when judging what a financing can support. For now, the concrete point is that investors have committed a large sum to advance the company’s therapies through trials.
Group14 Technologies raised $169 million in a Series D extension. The Woodinville, Washington-based supplier of silicon battery materials also announced plans for a production facility in Sagunto, Spain, marking an expansion into Europe. The financing and facility plan connect the company’s technology ambitions to manufacturing capacity: materials suppliers have to produce at a scale and consistency that battery customers can use. The announcement doesn't give a schedule or capacity for the Spanish site, so the plan’s eventual contribution remains unclear.
Firehawk Aerospace reported more than $150 million in Series D funding, led by Advent and Rochefort. The Dallas-based propulsion technology developer, founded seven years ago, said the financing values it at more than $1.4 billion. That valuation and round size suggest investor confidence in the company’s prospects, but the source doesn't describe how the funds will be spent or identify a specific operational milestone. The numbers here are underwhelming as a guide to execution: they show the scale of the financing, not what the company has yet delivered.
What the mix says about the funding week
The week’s announced rounds show capital reaching both physical systems, from manufacturing to construction and factory automation, and software and infrastructure tied to AI. Biotech, battery materials and propulsion add businesses with their own demands for development, production and testing. This is more significant than it looks: the list is not simply a vote for AI, since some of its largest financings support industrial production and a predictions marketplace. It’s a snapshot of investors backing companies that may need substantial capital to build, test or scale their products.
Still, a ranking of large rounds has limits. It highlights the biggest reported financings, not the full range of startup activity, and a large check doesn't establish that a company has found a repeatable business. The figures also aren't directly comparable across sectors: a clinical-stage therapeutics developer, an industrial producer and a software company face different costs and milestones. What this means for you is that the headline totals are best read as evidence of where large investors are committing capital, not as a measure of which business models have already been proven.
Funding window and methodology
The list covers the largest announced rounds raised by U.S.-based companies from Oct. 24-30, 2026, according to the Crunchbase database. Some deals may appear with a delay when reported late in the week, which means the lineup reflects the database’s reported information for that window rather than every financing that may have closed during it. A weekly ranking can shift as late reports arrive. The dates and company locations also define the list’s scope, so the selection shouldn't be read as a complete account of funding activity across all markets.
Illustration: Dom Guzman
